Axicabtagene ciloleucel, commonly known as axi-cel, is an innovative immunotherapy that uses modified T cells to target and destroy cancer cells. Approved for patients who have not responded to at least two prior lines of therapy, axicabtagene ciloleucel has been a game-changer in treating large B-cell lymphoma.
Study answers questions about long-term survivorship following CAR T treatment retrieved 5 August 2024 from https://medicalxpress.com/news/2024-08-term-survivorship-car-treatment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.1 hour ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Preclinical study explores approved drug for ovarian cancerAn iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.
Read more »
Study highlights infection as major post-CAR-T therapy challengeIn patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL), the two hallmark post-chimeric antigen receptor (CAR)-T therapy toxicities are extremely rare after two weeks, supporting a shorter, more flexible toxicity monitoring period, according to a study published in Blood Advances.
Read more »
Study highlights the importance of infection prevention after CAR T-cell therapyResearchers at Dana-Farber Cancer Institute, in collaboration with colleagues from Memorial Sloan Kettering Cancer Center in New York (Dr. Kai Rejeski) and the LMU Hospital in Munich, Germany (Dr.
Read more »
Scene of chaos as car lands on side after four-car crashOne person was injured in the collision in Newton Heath
Read more »
Top car brand that sells millions of motors to decide fate of TWO UK car factoriesVauxhall Frontera walk round VIDEO with Brit design chief Mark Adams
Read more »
Police hunting three men after woman forced out of car in car-jackingThree men are being hunted by police after they forced a female driver out of a car on a rural Shropshire road before stealing it.
Read more »